HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pilot study to assess the presence of Chlamydia trachomatis in urine from 18-30-year-old males using EIA/IF and PCR.

AbstractCONTEXT:
To increase detection, urine samples from young males could be opportunistically tested for Chlamydia trachomatis.
OBJECTIVE:
To determine C. trachomatis prevalence in urine, optimum specimen and compare sensitivity/feasibility of routine use of different testing methods.
DESIGN:
Group A, 'sterile' pyuria samples June 1998-January 1999, tested by enzyme immunoassay (EIA) and, if reactive, by immunofluorescence (IF). Subsequently batch-tested by polymerase chain reaction (PCR). Group B, consecutive urine samples October 1998-January 1999; batch-tested by PCR.
SETTING:
Microbiology laboratory.
SAMPLES:
From males aged 18-30 years; group A = 71, group B = 83.
MAIN OUTCOME MEASURES:
Chlamydia trachomatis positive if EIA- and IF- or PCR-positive.
RESULTS:
Group A: 12 EIA/IF-positive; 9/12 and 15 EIA-negative samples PCR-positive. Group B: 11 PCR-positive; 8/11 showed 'sterile' pyuria.
CONCLUSIONS:
Opportunistic testing of urine from young men shows a significant number of C. trachomatis infections. 'Sterile' pyuria samples are optimal. EIA/IF are less sensitive than PCR but can be routinely performed and detect a significant proportion of cases.
AuthorsAdriana Basarab, David Browning, Stuart Lanham, Susan O'Connell
JournalThe journal of family planning and reproductive health care (J Fam Plann Reprod Health Care) Vol. 28 Issue 1 Pg. 36-7 (Jan 2002) ISSN: 1471-1893 [Print] England
PMID16259815 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Chlamydia Infections (epidemiology, urine)
  • Chlamydia trachomatis (isolation & purification)
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Pilot Projects
  • Polymerase Chain Reaction
  • Prevalence
  • Sensitivity and Specificity
  • United Kingdom (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: